Seeking Alpha

SciClone Pharmaceuticals (SCLN) -14.1% premarket after announcing that a special committee found...

SciClone Pharmaceuticals (SCLN) -14.1% premarket after announcing that a special committee found evidence of sales and marketing activities that might violate the Foreign Corrupt Practices Act, leading its president of international sales to resign. The drugmaker yesterday reported a decline in Q1 profit.

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs